Ensign Peak Advisors, Inc Biomarin Pharmaceutical Inc Transaction History

Ensign Peak Advisors, Inc

$56.1 Billion
Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 67,863 shares of BMRN stock, worth $4.52 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

67,863

Previous 71,888 5.6%

Holding current value

$4.52 Million

Previous $5.92 Million 19.4%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$69.02 - $93.84 $277,805 - $377,706	-4,025 Reduced 5.6%	67,863 $4.77 Million
Q2 2024 Aug 13, 2024	SELL	$74.43 - $92.22 $20,840 - $25,821	-280 Reduced 0.39%	71,888 $5.92 Million
Q1 2024 May 14, 2024	SELL	$83.81 - $99.0 $7.19 Million - $8.49 Million	-85,808 Reduced 54.32%	72,168 $6.3 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $2.9 Million - $3.75 Million	38,095 Added 31.78%	157,976 $15.2 Million
Q3 2023 Nov 13, 2023	SELL	$85.07 - $94.48 $176,094 - $195,573	-2,070 Reduced 1.7%	119,881 $10.6 Million
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $1.41 Million - $1.63 Million	16,252 Added 15.38%	121,951 $10.6 Million
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $12 Million - $16 Million	-136,402 Reduced 56.34%	105,699 $10.3 Million
Q4 2022 Feb 13, 2023	BUY	$80.93 - $108.63 $1.82 Million - $2.45 Million	22,529 Added 10.26%	242,101 $25.1 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $10.6 Million - $12.5 Million	129,246 Added 143.09%	219,572 $18.6 Million
Q2 2022 Aug 12, 2022	BUY	$71.48 - $86.85 $3.21 Million - $3.9 Million	44,936 Added 99.0%	90,326 $7.49 Million
Q1 2022 May 16, 2022	SELL	$74.28 - $92.69 $579,384 - $722,982	-7,800 Reduced 14.66%	45,390 $3.5 Million
Q4 2021 Feb 11, 2022	BUY	$71.72 - $91.47 $3.81 Million - $4.87 Million	53,190 New	53,190 $4.7 Million
Q4 2020 Feb 12, 2021	SELL	$72.61 - $90.2 $1.2 Million - $1.48 Million	-16,459 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$71.87 - $131.03 $1.18 Million - $2.16 Million	16,459 New	16,459 $1.25 Million
Q1 2020 May 11, 2020	SELL	$71.37 - $96.85 $752,953 - $1.02 Million	-10,550 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $678,048 - $911,203	10,550 New	10,550 $892,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Biomarin Pharmaceutical Inc Transaction History